INARI MEDICAL INC (NARI) Stock Analyst Earnings Estimates
NASDAQ:NARI - Nasdaq - US45332Y1091 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 277M 98.28% | 383.5M 38.45% | 493.632M 28.72% | 615.15M 24.62% | 725.85M 18.00% | 846.21M 16.58% | 1.005B 18.76% | 1.124B 11.84% | 1.276B 13.52% | 1.224B -4.08% | |
| EBITDA YoY % growth | 13.83M -31.16% | -23.43M -269.41% | 3.258M 113.91% | -29.641M -1,009.80% | 27.908M 194.15% | 54.593M 95.62% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | 10.8M -42.25% | -28.1M -360.19% | -3.632M 87.07% | -28.224M -677.09% | 9.512M 133.70% | 36.661M 285.42% | 61.506M 67.77% | 109.24M 77.61% | 185.54M 69.85% | N/A | |
| Operating Margin | 3.90% | -7.33% | -0.74% | -4.59% | 1.31% | 4.33% | 6.12% | 9.72% | 14.54% | N/A | |
| EPS YoY % growth | 0.16 -27.27% | -0.55 -443.75% | -0.03 94.55% | -0.78 -2,492.94% | 0.20 125.35% | 0.68 245.15% | 0.95 39.37% | 1.53 61.29% | 2.45 60.00% | N/A |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.01 106.52% | -0.02 91.76% | 0.02 106.26% | 0.08 191.92% | 0.11 2,101.57% | 0.04 324.97% | 0.06 157.18% | 0.07 -13.70% | 0.10 -11.11% |
| Revenue Q2Q % growth | 163.82M 24.02% | 172.16M 20.23% | 175.41M 20.29% | 184.33M 20.17% | 193.61M 18.18% | 207.57M 20.57% | 213.08M 21.48% | 223.99M 21.52% | 235.42M 21.59% |
| EBITDA Q2Q % growth | 4.273M -46.54% | 1.21M 111.49% | 4.408M 132.26% | 6.418M 571.57% | 9.412M 120.27% | 3.876M 220.33% | 5.916M 34.21% | 6.732M 4.89% | 8.772M -6.80% |
| EBIT Q2Q % growth | -1.015M -192.06% | -2.083M 85.53% | 1.07M 105.00% | 4.299M 132.47% | 6.516M 741.71% | -102K 95.10% | 1.836M 71.59% | 2.55M -40.68% | 4.59M -29.56% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.09 -280.00% | -0.13 | 0.04 | 31.16% |
| Q2 2024 Q2Q % growth | -0.38 -1,050.00% | -0.15 | -0.23 | -154.00% |
| Q1 2024 Q2Q % growth | -0.22 -450.00% | -0.20 | -0.02 | -7.77% |
| Q4 2023 Q2Q % growth | -0.08 27.27% | 0.01 | -0.09 | -1,407.19% |
| Q3 2023 Q2Q % growth | 0.05 126.32% | 0.00 | 0.05 | 1,004.05% |
| Q2 2023 Q2Q % growth | 0.04 121.05% | -0.13 | 0.17 | 131.02% |
| Q1 2023 Q2Q % growth | -0.04 33.33% | -0.23 | 0.19 | 82.67% |
| Q4 2022 Q2Q % growth | -0.11 -650.00% | -0.17 | 0.06 | 37.03% |
| Q3 2022 Q2Q % growth | -0.19 -216.67% | -0.26 | 0.07 | 26.59% |
| Q2 2022 Q2Q % growth | -0.19 -371.43% | -0.23 | 0.04 | 19.01% |
| Q1 2022 Q2Q % growth | -0.06 -146.15% | -0.09 | 0.03 | 35.83% |
| Q4 2021 Q2Q % growth | 0.02 -84.62% | 0.03 | -0.01 | -24.59% |
| Q3 2021 Q2Q % growth | -0.06 -150.00% | -0.11 | 0.05 | 46.52% |
| Q2 2021 Q2Q % growth | 0.07 143.75% | 0.08 | -0.01 | -15.97% |
| Q1 2021 Q2Q % growth | 0.13 | 0.05 | 0.08 | 146.66% |
| Q4 2020 Q2Q % growth | 0.13 | 0.01 | 0.12 | 856.12% |
| Q3 2020 Q2Q % growth | 0.12 | -0.04 | 0.16 | 409.60% |
| Q2 2020 Q2Q % growth | -0.16 | -0.18 | 0.02 | 11.21% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 153.39M 21.39% | 153.68M | -290K | -0.19% |
| Q2 2024 Q2Q % growth | 145.82M 22.53% | 146.62M | -800K | -0.55% |
| Q1 2024 Q2Q % growth | 143.194M 23.27% | 141.14M | 2.054M | 1.46% |
| Q4 2023 Q2Q % growth | 132.094M 22.54% | 134.42M | -2.326M | -1.73% |
| Q3 2023 Q2Q % growth | 126.366M 31.36% | 124.36M | 2.006M | 1.61% |
| Q2 2023 Q2Q % growth | 119.005M 28.38% | 118.96M | 45K | 0.04% |
| Q1 2023 Q2Q % growth | 116.167M 33.83% | 112.5M | 3.667M | 3.26% |
| Q4 2022 Q2Q % growth | 107.8M 29.57% | 106.94M | 860K | 0.80% |
| Q3 2022 Q2Q % growth | 96.2M 31.96% | 92.21M | 3.99M | 4.33% |
| Q2 2022 Q2Q % growth | 92.7M 45.98% | 89.558M | 3.142M | 3.51% |
| Q1 2022 Q2Q % growth | 86.8M 51.22% | 85.281M | 1.519M | 1.78% |
| Q4 2021 Q2Q % growth | 83.2M 71.19% | 79.721M | 3.479M | 4.36% |
| Q3 2021 Q2Q % growth | 72.9M 88.37% | 64.291M | 8.609M | 13.39% |
| Q2 2021 Q2Q % growth | 63.5M 150.00% | 60.839M | 2.661M | 4.37% |
| Q1 2021 Q2Q % growth | 57.4M 112.59% | 56.238M | 1.162M | 2.07% |
| Q4 2020 Q2Q % growth | 48.6M 144.22% | 41.905M | 6.695M | 15.98% |
| Q3 2020 Q2Q % growth | 38.7M 172.54% | 27.065M | 11.635M | 42.99% |
| Q2 2020 Q2Q % growth | 25.4M 151.49% | 13.413M | 11.987M | 89.37% |
| Q1 2020 Q2Q % growth | 27M 291.30% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 250.29% | 250.29% | -2.57% | -2.25% |
| Revenue | -0.01% | 0.07% | 0% | 0.02% |